Latest Market Expansion News

archTIS has renewed 1,000 NC Protect licenses within the U.S. Department of Defense’s Microsoft DoD365 environment and secured an $8 million debt facility to accelerate its U.S. market expansion.

4DMedical secures Cleveland Clinic as the third major US academic medical centre to adopt its CT – VQ™ respiratory imaging technology, marking rapid commercial traction post-FDA clearance.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Credit Clear Limited has agreed to acquire DTS, a SaaS collections business with a 35-year history, for A$7.75 million, enhancing its digital platform and global footprint. The deal is expected to be earnings accretive and unlock new growth opportunities across multiple international markets.

Orthocell has reached a significant milestone with 100 units of its nerve repair product Remplir™ sold in the US, signaling accelerating adoption in a $1.6 billion market. The company’s strategic medical education and distributor network are driving momentum ahead of further hospital approvals.

SKS Technologies has formalised its acquisition of Delta Elcom, a specialist electrical and communications firm, aiming to boost its market share in New South Wales' data centre sector and beyond.

PointsBet Holdings Limited has appointed Andrew Catterall as Group CEO effective February 2026, with founder Sam Swanell transitioning to an advisory role while remaining on the Board.

CONNEQT Health’s Pulse arterial health monitor sales have outpaced expectations with over 200% growth in the December quarter, driven by efficient marketing and early subscription uptake.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.

Genetic Signatures announces the upcoming departure of CEO Allison Rossiter, initiating a leadership transition as the company intensifies its focus on US market expansion.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.